By Jeff Overley ( September 16, 2015, 5:12 PM EDT) -- Amgen Inc. said Wednesday it will pay $300 million in up-front cash and up to $1.25 billion in bonus payments for Netherlands startup Dezima Pharma BV, a deal aimed at enhancing and protecting the California drugmaker's lucrative portfolio of cardiovascular drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.